You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
疫苗股漲幅擴大 鍾南山表示國產疫苗對德爾塔依舊有效 加強針實驗效果良好
格隆匯8月23日丨疫苗股漲幅擴大,康希諾生物大漲近11%,復星醫藥漲超7%,持有科興股權的中國生物製藥則漲2.22%。

中國工程院院士鍾南山日前在廣州出席一峯會活動時表示,基於今年5月份廣州新冠病毒德爾塔變異株暴發疫情的研究,結果證明國產疫苗是有保護作用的。研究初步統計顯示,疫苗對重症的保護效果為100%,對中度、輕度、無症狀的保護效果分別為76.9%、67.2%、63.2%。他指出,我國需要83.3%的接種率才能達到羣體免疫。

鍾南山還表示,國內最新的實驗資料證明,經過一針加強之後,其產生的幾何的平均抗體水平明顯增高,差不多增加了十幾倍。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account